ABATACEPT
UNII 7D0YB67S97

Substance Identification & Data

This profile provides standardized clinical and technical data for Abatacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7D0YB67S97.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 332348-12-6 and the RxNorm Concept ID (RxCUI) 614391. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7D0YB67S97

CAS Registry Number

332348-12-6

RxNorm Concept ID

614391

Detailed Substance Profile

Preferred Name

ABATACEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

7D0YB67S97

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C28898

National Cancer Institute reference terminology for clinical and research data.

INN ID

8495

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NN-82

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abatacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABATACEPT

Common Names & Synonyms

1-25-ONCOSTATIN M (HUMAN PRECURSOR) FUSION PROTEIN WITH CTLA-4 (ANTIGEN) (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN HEAVY CHAIN FRAGMENT) (RECOMBINANT)

ABATACEPT (GENETICAL RECOMBINATION)

ABATACEPT (GENETICAL RECOMBINATION) [JAN]

ABATACEPT [EMA EPAR]

ABATACEPT [INN]

ABATACEPT [JAN]

ABATACEPT [MART.]

ABATACEPT [MI]

ABATACEPT [PURPLE BOOK CDER]

ABATACEPT [USAN]

ABATACEPT [VANDF]

ABATACEPT [WHO-DD]

ABATACEPT RECOMBINANT